Literature DB >> 9534837

Informing patients about tardive dyskinesia. Controlled trial of patient education.

R Chaplin1, A Kent.   

Abstract

BACKGROUND: This paper evaluates the effects on knowledge and clinical stability of an educational intervention about tardive dyskinesia.
METHOD: Fifty-six patients receiving antipsychotic maintenance completed a questionnaire assessing their knowledge about tardive dyskinesia. After random allocation to either an educational intervention or a control group, their knowledge was reassessed at six months.
RESULTS: Ninety-five per cent of patients completed the study. The study patients gained significantly more knowledge than the controls, who made modest gains. There were no significant differences in clinical outcome between the groups.
CONCLUSION: Patients can learn about serious toxic effects of antipsychotic treatment with a low risk of non-compliance. Discussion about tardive dyskinesia is necessary in the process of obtaining informed consent to treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534837     DOI: 10.1192/bjp.172.1.78

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  10 in total

1.  Potential negative impact of informing patients about medication side effects: a systematic review.

Authors:  Jimmy Jose; Lamia AlHajri
Journal:  Int J Clin Pharm       Date:  2018-08-23

Review 2.  Psychoeducation for schizophrenia.

Authors:  Jun Xia; Lars Bertil Merinder; Madhvi R Belgamwar
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 3.  The impact of informing psychiatric patients about their medication: a systematic review.

Authors:  Franciska A M Desplenter; Steven Simoens; Gert Laekeman
Journal:  Pharm World Sci       Date:  2007-01-10

4.  The risks of multimedia methods: effects of actor's race and gender on preferences for health states.

Authors:  L A Lenert; J Ziegler; T Lee; C Unfred; R Mahmoud
Journal:  J Am Med Inform Assoc       Date:  2000 Mar-Apr       Impact factor: 4.497

Review 5.  Patient-oriented strategies for the prevention of drug interactions.

Authors:  C P Alderman
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

6.  Enhancing patient satisfaction and increasing treatment compliance: patient education as a fundamental component of PTSD treatment.

Authors:  Matt J Gray; Jon D Elhai; B Christopher Frueh
Journal:  Psychiatr Q       Date:  2004

Review 7.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

8.  [Patient knowledge regarding tardive dyskinesia].

Authors:  E M Haberfellner; H Rittmannsberger
Journal:  Nervenarzt       Date:  2006-03       Impact factor: 1.214

9.  Frequency and effects of psychosocial interventions additional to olanzapine treatment in routine care of schizophrenic patients.

Authors:  Michael Linden; Lena Pyrkosch; Hans-Peter Hundemer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-05       Impact factor: 4.328

Review 10.  Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

Authors:  Karla Soares-Weiser; John Rathbone; Yusuke Ogawa; Kiyomi Shinohara; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.